Glucagon-like peptide 1(7-36) amide stimulates exocytosis in human pancreatic β-cells by both proximal and distal regulatory steps in stimulus- secretion coupling

Diabetes

Volumn 47, Issue 1, 1998, Pages 57-65

  Gromada, Jesper ^a,e   Bokvist, Krister ^a   Ding, Wei Guang ^a   Holst, Jens Juul ^b   Nielsen, Jens Høøiriis ^c   Rorsman, Patrik ^d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c HAGEDORN RESEARCH INSTITUTE   (Denmark)

^d LUND UNIVERSITY   (Sweden)

^e NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; FORSKOLIN; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; POTASSIUM ION; SOMATOSTATIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALCIUM CELL LEVEL; EXOCYTOSIS; FEMALE; GLUCAGON RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MEMBRANE POTENTIAL; PANCREAS ISLET BETA CELL; POTASSIUM CURRENT; PRIORITY JOURNAL; STIMULUS SECRETION COUPLING;

EID: 0031965604     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.47.1.57     Document Type: Article

References (47)

1. Fehmann HC, Göke R, Göke B: Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr Rev 16:390-410, 1995
2. Creuztfeld W, Nauck M: Gut hormones and diabetes mellitus. Diabetes Metab Rev 8:149-177, 1992
3. Gutniak M, Ørskov C, Holst JJ, Ahrén B, Efendic S: Antidiabetogenic effects of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326:1316-1322, 1992
4. Nauck MA, Heimasaat MM, Ørskov C, Holst JJ, Ebert R, Creutzfeld W: Preserved incretin activity of glucagon-like peptide 1[7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 91:301-307, 1993
5. Thorens B: Expression cloning of the pancreatic β cell receptor for the glucoincretin hormone glucagon-like peptide 1. Proc Nat Acad Sci USA 89:8641-8645, 1992
6. Thorens B, Porret A, Bühler L, Deng SP, Morrel P, Widmann C: Cloning and functional expression of the human islet GLP-1 receptor. Diabetes 42:1678-1682, 1993
7. Gromada J, Rorsman P, Dissing S, Wulff BS: Stimulation of cloned human glucagon-like peptide 1 receptor expressed in HEK 293 cells induces cAMP-dependent activation of calcium-induced calcium release. FEBS Lett 373:182-186, 1995
8. Holz GG, Kühtreiber WM, Habener JF: Pancreatic beta-cells are rendered glucose-competent by insulinotropic hormone glucagon-like peptide-1-(7-37). Nature 361:362-366, 1993
9. Gromada J, Ding WG, Barg S, Renström E, Rorsman P: Multisite regulation of insulin secretion by cyclic AMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors. Pflugers Archiv 434:515-524, 1997
10. + current in intact pancreatic β-cells. Biochem Biophys Res Commun 207:33-39, 1995
11. Gromada J, Dissing S, Bokvist K, Renström E, Frøkjær-Jensen J, Wulff BS, Rorsman P: Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting βTC3-cells by enhancement of intracellular calcium mobilization. Diabetes 44:767-774, 1995
12. Wheeler MB, Lu M, Dillon JS, Leng XH, Chen C, Boyd AE: Functional expression of the rat glucagon-like peptide-1 receptor, evidence for coupling to both adenylate cyclase and phospholipase-C. Endocrinology 133:57-62, 1993
13. Ämmälä C, Ashcroft FM, Rorsman P: Calcium-independent potentiation of insulin release by cyclic AMP in single β-cells. Nature 363:356-358, 1993
14. Jones PM, Fyles JM, Howell SL: Regulation of insulin secretion by cAMP in rat islets of Langerhans permeabilized by high-voltage discharge. FEBS Lett 205:205-209, 1986
15. Renström E, Eliasson L, Bokvist K, Rorsman P: Cooling inhibits exocytosis in single mouse β-cells by suppression of granule mobilization. J Physiol 494:41-52, 1996
16. Ding WG, Gromada J: Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic β-cells by glucose-dependent insulinotropic polypeptide. Diabetes 46:615-621, 1997
17. Ämmälä C, Eliasson L, Bokvist K, Larsson O, Ashcroft FM, Rorsman P: Exocytosis elicited by action potentials and voltage-clamp calcium currents in individual mouse pancreatic β-cells. J Physiol 472:665-688, 1993
18. Neher E, Marty A: Discrete changes of cell membrane capacitance observed under conditions of enhanced secretion in bovine adrenal chromaffin cells. Proc Natl Acad Sci USA 79:6712-6716, 1982
19. Pipeleers D: Treatment of diabetes by islet cell transplantation. In Biomedical and Health Research, Advances in Medical Biology. Baya C, Ed. Amsterdam, Netherlands, IOS Press, 1994, p. 185-197
20. Eizirik DL, Korbutt GS, Hellerström C: Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. J Clin Invest 90:1263-1268, 1992
21. Nielsen JH, Brunsted J, Andersson A, Frimodt-Møller C: Preservation of beta-cell function in adult human pancreatic islets for several months. Diabetologia 16:97-100, 1979
22. Ling ZD, Pipeleers DG: Prolonged exposure of human beta-cells to elevated glucose-levels results in sustained cellular activation leading to a loss of glucose regulation. J Clin Invest 98:2805-2812, 1996
23. Horn R, Marty A: Muscarinic activation of ionic currents measured by a new whole-cell recording method. J Gen Physiol 92:145-159, 1988
24. 2+ channels and insulin-containing secretory granules and its significance for the initiation of exocytosis in mouse pancreatic β-cells. EMBO J 14:50-57, 1995
25. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450, 1985
26. Rorsman P, Trube G: Calcium and delayed potassium currents in mouse pancreatic β-cells under voltage-clamp conditions. J Physiol 374:531-550, 1986
27. Rae J, Cooper K, Gates P, Watsky M: Low access resistance perforated patch recordings using amphotericin B. J Neurosci Methods 37:15-26, 1991
28. Martell AE, Smith RM: Critical Stability Constants. Amino Acids (Vol. 1) and Amines (Vol. 2). Plenum Press, New York, 1971
29. Pressel DM, Misler S: Sodium channels contribute to action potential generation in canine and human pancreatic islet B cells. J Membrane Biol 116:27:3-280, 1990
30. 2+-signaling pathway in pancreatic β-cells by the insulinotropic hormone glucagon-like peptide-1. J Biol Chem 270:17749-17757, 1995
31. De Witt JM, Hekstra D, Jastrorff B, Stec VJ, Baraniak J, Van Driel R, Van Haastrert JM: Inhibitory action of certain cyclophosphate derivates of cAMP on cAMP-dependent protein kinases. Eur J Biochem 42:255-260, 1984
32. Gromada J, Dissing S, Rorsman P: Desensitization of glucagon-like peptide 1 receptors in insulin-secreting βTC3 cells: role of PKA-independent mechanisms. Br J Pharmacol 118:769-775, 1996
33. Liu Y-J, Grappengiesser E, Gylfe E, Hellman B: Crosstalk between the cAMP and inositol trisphosphate-signalling pathways in pancreatic β-cells. Arch Biochem Biophys 334:295-302, 1996
34. Fehmann HC, Hering BJ, Wolf MJ, Brandhorst H, Brandhorst D, Bretzel R, Fedelin K, Göke B: The effects of glucagon-like peptide-1 (GLP-1) on hormone secretion from isolated human pancreatic islets. Pancreas 11:196-200, 1995
35. Göke R, Fehmann HC, Richter G, Trautmann M, Göke B: Interaction of glucagon-like peptide-1 (7-36) amide and somatostatin-14 in RINmF cells and in the perfused rat pancreas. Pancreas 4:668-673, 1989
36. + channel in human pancreatic islet cells. Diabetes 38:422-427, 1989
37. Ashcroft FM, Kakei M, Gibson JS, Gray DW, Sutton R: The ATP- and tolbutamide-sensitivity of the ATP-sensitive K channel from human pancreatic β cells. Diabetologia 32:591-598, 1989
38. Kelly RP, Sutton R, Ashcroft FM: Voltage-activated calcium and potassium currents in human pancreatic β-cells. J Physiol 443:175-192, 1991
39. Barnett DW, Pressel DM, Chern HT, Scharp DW, Misler S: cAMP-enhancing agents "permit" stimulus-secretion coupling in canine pancreatic beta-cells. J Membr Biol 138:113-120, 1994
40. +-dependent manner. Regul Pept 62:23-27, 1996
41. Renström E, Eliasson L, Rorsman P: PKA-independent and PKA-dependent stimulation of exocytosis by cAMP in mouse pancreatic β-cells. J Physiol 502:105-118, 1997
42. 2+-induced exocytosis in mouse pancreatic β-cells. J Physiol 503:399-412, 1997
43. Renström E, Ding W-G, Bokvist K, Rorsman P: Neurotransmitter-induced inhibition of exocytosis in insulin-secreting β cells by activation of calcineurin. Neuron 17:513-522, 1996
44. Gremlich S, Porret A, Hani EH, Cherif D, Vionnet N, Froguel P, Thorens B: Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor. Diabetes 44:1202-1208, 1995
45. Nauck M, Stöckmann R, Ebert R, Creutzfeld W: Reduced incretin effect in type-2 (non-insulin-dependent) diabetes. Diabetologia 29:46-52, 1986
46. Vaag AA, Holst JJ, Vølund A, Beck-Nielsen H: Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): evidence for decreased glucagon-like peptide-1 secretion during oral glucose ingestion in NIDDM twins. Eur J Endocrinol 135:435-442, 1996
47. Holst JJ, Gromada J, Nauck MA: The pathogenesis of non-insulin dependent diabetes mellitus involves a defective expression of the GIF receptor. Diabetologia 40:984-986, 1997